Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

25%(1 trials)

Phase Distribution

Ph phase_2

20%

Ph phase_3

40%

Ph not_applicable

20%

Ph phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

1(20.0%)

Phase 2Efficacy & side effects

1(20.0%)

Phase 3Large-scale testing

2(40.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Other(1)

Detailed Status

Completed4

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (20.0%)

Phase 21 (20.0%)

Phase 32 (40.0%)

N/A1 (20.0%)

Trials by Status

completed480%

unknown120%

Recent Activity

0 active trials

Showing 5 of 5

completedphase_2

Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer

NCT00691678

completedphase_1

Clinical Trials (5)

Showing 5 of 5 trials

NCT00691678Phase 2

Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer

Completed

NCT03827161Phase 1

Glucosamine and Chondroitin in Preventing Inflammation in Overweight Patients

Completed

NCT02448199Phase 3

Study of Association of Anti-inflammatory and Anti-rheumatic

Unknown

NCT00032890Phase 3

Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)

Completed

NCT00086229Not Applicable

Absorption and Distribution of Glucosamine and Chondroitin

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5